Lung Cancer, Huntingtons and Alzheimers Treatments Gain Innovation Passports

UK Gov

Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington's disease and Alzheimer's disease have been given Innovation Passports, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.